Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Deferred Taxes: 2013-2024

Historic Deferred Taxes for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $131.5 million.

  • Surgery Partners' Deferred Taxes rose 8888.89% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 7656.25%. This contributed to the annual value of $131.5 million for FY2024, which is 783529.41% up from last year.
  • Per Surgery Partners' latest filing, its Deferred Taxes stood at $131.5 million for FY2024, which was up 783529.41% from -$1.7 million recorded in FY2023.
  • Surgery Partners' Deferred Taxes' 5-year high stood at $131.5 million during FY2024, with a 5-year trough of -$21.9 million in FY2020.
  • Its 5-year average for Deferred Taxes is $27.7 million, with a median of $8.9 million in 2021.
  • As far as peak fluctuations go, Surgery Partners' Deferred Taxes crashed by 35764.71% in 2020, and later soared by 783529.41% in 2024.
  • Annual analysis of 5 years shows Surgery Partners' Deferred Taxes stood at -$21.9 million in 2020, then soared by 140.64% to $8.9 million in 2021, then skyrocketed by 146.07% to $21.9 million in 2022, then tumbled by 107.76% to -$1.7 million in 2023, then surged by 7835.29% to $131.5 million in 2024.
  • Its Deferred Taxes stands at $131.5 million for FY2024, versus -$1.7 million for FY2023 and $21.9 million for FY2022.